TCOV
GMED icon

Trust Company of Vermont’s Globus Medical GMED Stock Holding History

Trust Company of Vermont’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-134
Closed -$7.59K – 860
2023
Q1 		$7.59K Hold
134
– – ﹤0.01% 740
2022
Q4 		$9.95K Sell
134
-43
-24% -$2.93K ﹤0.01% 693
2022
Q3 		$11K Buy
177
+43
+32% +$2.59K ﹤0.01% 699
2022
Q2 		$8K Buy
+134
New +$8.81K ﹤0.01% 724

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Trust Company of Vermont's GMED Position: Q2 2023 in Review

Trust Company of Vermont sold out of Globus Medical (GMED) in Q2 2023, closing a stake of 134 shares — an estimated $7.59K sold.

Trust Company of Vermont first reported a position in GMED in Q2 2022 and held it in 4 quarters. The position peaked at $11K in Q3 2022. 382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • Trust Company of Vermont reported no remaining Globus Medical position as of Q2 2023 after selling out during the quarter.
  • Trust Company of Vermont sold 134 Globus Medical shares in Q2 2023, an estimated $7.59K.
  • Trust Company of Vermont first reported a position in Globus Medical in Q2 2022 and held it in 4 quarters.
  • Trust Company of Vermont's Globus Medical position peaked at $11K in Q3 2022.
  • 382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on Trust Company of Vermont's 13F filing for Q2 2023, filed 17 Jul 2023.